Merit Medical Net Worth
Merit Medical Net Worth Breakdown | MMSI |
Merit Medical Net Worth Analysis
Merit Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Merit Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Merit Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Merit Medical's net worth analysis. One common approach is to calculate Merit Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Merit Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Merit Medical's net worth. This approach calculates the present value of Merit Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Merit Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Merit Medical's net worth. This involves comparing Merit Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Merit Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Merit Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Merit Medical's net worth research are outlined below:
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Are You a Growth Investor This 1 Stock Could Be the Perfect Pick |
Merit Medical Quarterly Good Will |
|
Merit Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Merit Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Merit Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Merit Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Merit Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merit Medical Systems backward and forwards among themselves. Merit Medical's institutional investor refers to the entity that pools money to purchase Merit Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.2 M | Amvescap Plc. | 2024-06-30 | 1.2 M | Loomis, Sayles & Company Lp | 2024-06-30 | 1.1 M | Royal Bank Of Canada | 2024-06-30 | 947.6 K | Greenhouse Funds Lllp | 2024-06-30 | 925.9 K | Aristotle Capital Boston, Llc | 2024-06-30 | 794.6 K | Norges Bank | 2024-06-30 | 782.7 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 780.5 K | Charles Schwab Investment Management Inc | 2024-09-30 | 727.3 K | Blackrock Inc | 2024-06-30 | 8.9 M | Vanguard Group Inc | 2024-09-30 | 6.6 M |
Follow Merit Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.14 B.Market Cap |
|
Project Merit Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.05 | |
| Return On Capital Employed | 0.06 | 0.10 | |
| Return On Assets | 0.04 | 0.05 | |
| Return On Equity | 0.08 | 0.05 |
When accessing Merit Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Merit Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Merit Medical's profitability and make more informed investment decisions.
Evaluate Merit Medical's management efficiency
Merit Medical Systems has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.094 %, meaning that it created $0.094 on every $100 dollars invested by stockholders. Merit Medical's management efficiency ratios could be used to measure how well Merit Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Merit Medical's Return On Capital Employed is increasing as compared to previous years. The Merit Medical's current Return On Assets is estimated to increase to 0.05, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 342.2 M, while Other Assets are projected to decrease to under 25.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 20.87 | 21.91 | |
| Tangible Book Value Per Share | 8.58 | 9.00 | |
| Enterprise Value Over EBITDA | 20.21 | 12.59 | |
| Price Book Value Ratio | 3.64 | 3.60 | |
| Enterprise Value Multiple | 20.21 | 12.59 | |
| Price Fair Value | 3.64 | 3.60 | |
| Enterprise Value | 3.8 B | 4 B |
Leadership at Merit Medical emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue 4.8531 | Revenue 1.3 B | Quarterly Revenue Growth 0.078 | Revenue Per Share 22.847 | Return On Equity 0.094 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merit Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merit Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merit Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Merit Medical Corporate Filings
F4 | 18th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 29th of August 2024 Other Reports | ViewVerify |
Merit Medical Earnings per Share Projection vs Actual
Merit Medical Corporate Management
| CPA Parra | CFO Treasurer | Profile | |
| Sarah Comstock | Vice Communications | Profile | |
| JoAnne Alkire | Executive Strategy | Profile | |
| Neil Peterson | Chief Officer | Profile | |
| Joseph Pierce | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.